|
Ling, W; Shoptaw, S (1997) Integration of research in pharmacotherapy for addictive disease: where are we? Where are we going? J Addict Dis 16:83-102
|
|
Compton, P A; Ling, W; Wesson, D R et al. (1996) Urine toxicology as an outcome measure in drug abuse clinical trials: must every sample be analyzed? J Addict Dis 15:85-92
|
|
Ling, W; Wesson, D R; Charuvastra, C et al. (1996) A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry 53:401-7
|
|
Ling, W; Rawson, R A; Compton, M A (1994) Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and buprenorphine. J Psychoactive Drugs 26:119-28
|
|
Wesson, D R; Ling, W; Smith, D E (1993) Prescription of opioids for treatment of pain in patients with addictive disease. J Pain Symptom Manage 8:289-96
|
|
Gawin, F H (1991) Cocaine addiction: psychology and neurophysiology. Science 251:1580-6
|
|
Rawson, R A; Ling, W (1991) Opioid addiction treatment modalities and some guidelines to their optimal use. J Psychoactive Drugs 23:151-63
|
|
Wesson, D R; Smith, D E (1990) Prescription drug abuse. Patient, physician, and cultural responsibilities. West J Med 152:613-6
|
